Investigators compared oncologic outcomes among patients with tumors in the bladder only vs in the bladder neck/urethra.

Antibody-drug conjugates combined with immunotherapy have redefined the standard of care for advanced bladder cancer, ...

Patients may report rust-colored urine or the passing of tissue, clots or blood. Approximately 10 percent of patients with hematuria will be found to have a bladder tumor. Frequently, however, urine ...

Oncologic outcomes following nephroureterectomy for upper tract urothelial carcinoma are not compromised when the surgeon removes the bladder cuff via a transurethral incision. Excision of the ...

The subtypes investigated in bladder cancer were CK19 ... information about the quality of lymph node sample along with tumor burden. Although not uniformly accepted, this index is the most ...

These results demonstrate that oncogenic activation of macropinocytosis determines uptake of BCG by bladder cancer cells, and imply that tumor responsiveness to BCG may be governed by the complement ...

During a live event, Matthew Galsky, MD, discussed adjuvant nivolumab in muscle-invasive bladder cancer and the benefit in ...

researchers developed a more effective model for predicting how patients with muscle-invasive bladder cancer will respond to chemotherapy. The model harnesses whole-slide tumor imaging data and ...

This ability to move allows them to be distributed more efficiently in the bladder, reaching tumor cells more precisely and ...